3 results
Primary ObjectiveTo assess the efficacy based on the proportion of subjects with SVR12, defined as HCV RNAgenotype 1 who are prior non-responders to pegIFNα-2a/RBV.Secondary Objectives• To assess efficacy, as determined by the proportion of subjects…
Primary ObjectiveThe primary objective of this clinical investigation is to evaluate the change in marginal bone levels (DMBL) of the On1 Concept from prosthetic delivery up to 1 year after prosthetic delivery.Secondary ObjectiveThe secondary…
The overall objective of the CAB LA + RPV LA clinical development programme is to develop a highly effective, well-tolerated, two-drug, long-acting injectable regimen which has the potential to offer improved treatment convenience, compliance and…